Skip to main content

Table 2 Quality assessment of included studies

From: Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis

References

Quality assessment

Random sequence generation

Allocation concealment

Blinding

Incomplete outcome data

Selective reporting

Bias from other resources

Ghanizadeh2013 [9]

Low risk

Low risk

Low risk

Low risk

Unclear

Low risk

Yoo 2013 [10]

Unclear

Unclear

Unclear

Low risk

Low risk

Low risk

Yoo 2011 [14] a

High risk

Unclear

High risk

Low risk

Unclear

Low risk

Wang 2013 [25]

High risk

Unclear

Unclear

Low risk

Unclear

High risk

Liu 2010 [26]

Unclear

Unclear

Unclear

Unclear

Unclear

Low risk

Liu 2011 [27]

High risk

Unclear

Unclear

Unclear

Unclear

Low risk

Cheng 2012 [28]

Unclear

Unclear

Unclear

Low risk

Unclear

High risk

Ren 2012 [29] a

Low risk

Unclear

High risk

Unclear

Unclear

Low risk

Zhao 2011 [30]

High risk

Unclear

Unclear

Unclear

Unclear

Low risk

Guo 2013[31]

Unclear

Unclear

Unclear

Low risk

Unclear

Low risk

Gao 2013 [32] a

Low risk

Unclear

High risk

Unclear

Unclear

Low risk

Liang 2010 [33]

High risk

Unclear

Unclear

Low risk

Unclear

Low risk

  1. a: they are open-label studies which did not use the method of blinding, so we justify them as high risk. Many studies did not mention the details of blinding, so we justify them as unclear